SHL Telemedicine (XSWX:SHLTN) Total Stockholders Equity: CHF34.88 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XSWX:SHLTN SHL Telemedicine Ltd XSWX:SHLTN
50 GF Score
Price CHF1.07
GF Value CHF2.63
Valuation Possible Value Trap
! 5 Warning Signs
View Full Analysis

What is SHL Telemedicine Total Stockholders Equity?

SHL Telemedicine XSWX:SHLTN 50 Total Stockholders Equity is CHF34.88 Mil as of Dec. 2025. GuruFocus rates XSWX:SHLTN with a GF Score™ of 50/100 and a GF Value™ of CHF2.63 (Possible Value Trap). The stock has 5 warning signs investors should review.

SHL Telemedicine's Total Stockholders Equity for the quarter that ended in Dec. 2025 was CHF34.88 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. SHL Telemedicine's Book Value per Share for the quarter that ended in Dec. 2025 was CHF0.94. The ratio of a company's debt over equity can be used to measure how leveraged this company is. SHL Telemedicine's Debt-to-Equity for the quarter that ended in Dec. 2025 was 0.30.

SHL Telemedicine  (XSWX:SHLTN) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

SHL Telemedicine's Book Value per Share for the quarter that ended in Dec. 2025 is

Book Value per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(34.881-0)/37.059
=0.94

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

SHL Telemedicine's Debt-to-Equity for the quarter that ended in Dec. 2025 is

Debt-to-Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(3.38 + 7.051) / 34.881
=0.30

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

SHL Telemedicine Total Stockholders Equity Related Terms

SHL Telemedicine Total Stockholders Equity Historical Data

* Premium members only.

The historical data trend for SHL Telemedicine's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

SHL Telemedicine Total Stockholders Equity Chart

SHL Telemedicine Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 52.36 51.88 63.59 34.99 34.88

SHL Telemedicine Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Total Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 63.59 60.17 34.99 30.93 34.88
XSWX:SHLTN
50GF Score
SHL Telemedicine Ltd XSWX:SHLTN
Total Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Total Stockholders Equity of CHF34.88 Mil mean?
SHL Telemedicine (XSWX:SHLTN) has a Total Stockholders Equity of CHF34.88 Mil as of Dec. 2025. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for SHL Telemedicine and its competitors.
Is SHL Telemedicine's Total Stockholders Equity too high?
SHL Telemedicine's current Total Stockholders Equity is CHF34.88 Mil. Overall, SHL Telemedicine has a GF Score™ of 50/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does SHL Telemedicine's Total Stockholders Equity compare to VEEV and BTSG?
SHL Telemedicine's Total Stockholders Equity of CHF34.88 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Stockholders Equity for a Healthcare Providers & Services company?
A good Total Stockholders Equity depends on the Healthcare Providers & Services industry context. However, Total Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Stockholders Equity mean?
A high Total Stockholders Equity can signal that a stock is expensive relative to its fundamentals. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for SHL Telemedicine and its competitors. SHL Telemedicine's current Total Stockholders Equity is CHF34.88 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SHL Telemedicine stock overvalued right now?
Based on GuruFocus' analysis, SHL Telemedicine (XSWX:SHLTN) is currently considered Possible Value Trap. The stock's GF Value™ is CHF2.63, compared to a current price of CHF1.07 — trading 59.3% below its estimated fair value. The current Total Stockholders Equity is CHF34.88 Mil. SHL Telemedicine's overall GF Score™ is 50/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Stockholders Equity calculated?
Total Stockholders Equity is calculated from a company's financial statements. For SHL Telemedicine (XSWX:SHLTN), the current Total Stockholders Equity is CHF34.88 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is SHL Telemedicine (XSWX:SHLTN) Overvalued in 2026?

Based on GuruFocus' analysis, SHL Telemedicine stock appears to be undervalued. The current stock price of CHF1.07 is trading 59.3% below its estimated GF Value™ of CHF2.63. GuruFocus considers SHL Telemedicine to be Possible Value Trap.

Key valuation signals for XSWX:SHLTN:

  • Total Stockholders Equity: CHF34.88 Mil
  • GF Value™: CHF2.63 vs. price of CHF1.07 (59.3% below fair value)
  • GF Score™: 50/100 with 5 warning signs

No single metric tells the full story. See the XSWX:SHLTN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

SHL Telemedicine Business Description

Other Exchanges 0QMX:UK
Address 90 Yigal Alon Street, Tel Aviv, ISR, 67891
SHL Telemedicine Ltd develops and markets personal telemedicine solutions. The company consists of the transmission of medical data by an individual, from a remote location to a medical call center, through telecommunication networks. The company provides healthcare professional solutions to patients suffering from congestive heart failure, chronic obstructive pulmonary disease, and readmission solutions for reducing heart-related readmissions. In addition, consumer solutions include cardiac monitoring services. The company's geographical segments are Israel, Europe, and the rest of the world, out of which majority of revenue comes from Israel.
50GF Score

Get the complete analysis for XSWX:SHLTN

Total Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF1.07
Price
CHF2.63
GF Value